4
Changes in Ownership
Olema Oncology, Inc. Filed Acc 0001415889-24-020461
Director sold 5,000 shares at an average $15.57 ($77,872)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Harmon Cyrus Director | 2024-07-29 | Sale 10b5-1 | −4,066 | $15.58 | $63,348 | 752,217 | D |
| Harmon Cyrus Director | 2024-07-30 | Sale 10b5-1 | −934 | $15.55 | $14,524 | 751,283 | D |
| Open-market sales · 5,000 sh · avg $15.57 · $77,872 | |||||||
Loading xslF345X05/form4-07312024_050701.xml…